GIPC1 knockdown decreased the PDGFR-α and PDGFR-β expression levels inhibited the PI3K/AKT signaling pathway, and subsequently led to impeded the proliferation and migration of GC cells. The gene discussed is AKT1; the disease is gastric cancer.